Coloplast A/S Stock

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 07:21:10 2024-04-24 am EDT 5-day change 1st Jan Change
922.7 DKK +0.67% Intraday chart for Coloplast A/S +2.35% +19.38%
Sales 2024 * 27.21B 3.9B Sales 2025 * 29.57B 4.24B Capitalization 206B 29.56B
Net income 2024 * 5.33B 765M Net income 2025 * 6.2B 889M EV / Sales 2024 * 8.27 x
Net Debt 2024 * 18.92B 2.72B Net Debt 2025 * 17.4B 2.5B EV / Sales 2025 * 7.56 x
P/E ratio 2024 *
38.4 x
P/E ratio 2025 *
33.1 x
Employees 15,751
Yield 2024 *
2.24%
Yield 2025 *
2.44%
Free-Float 58.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.75%
1 week+0.15%
Current month-1.69%
1 month-1.63%
3 months+18.42%
6 months+26.25%
Current year+18.73%
More quotes
1 week
888.00
Extreme 888
917.20
1 month
888.00
Extreme 888
947.20
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
993.00
3 years
689.20
Extreme 689.2
1 194.00
5 years
684.20
Extreme 684.2
1 194.00
10 years
413.10
Extreme 413.1
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Date Price Change Volume
24-04-24 921.6 +0.55% 23 174
24-04-23 916.6 +1.75% 163,807
24-04-22 900.8 -0.57% 189,725
24-04-19 906 +1.09% 175,872
24-04-18 896.2 -0.47% 165,299

Delayed Quote Nasdaq Copenhagen, April 23, 2024 at 10:59 am EDT

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
916.6 DKK
Average target price
917.1 DKK
Spread / Average Target
+0.05%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock